Thalidomide-induced hemorrhagic rash in a patient with myelofibrosis and delta-granule storage pool disease.
Thalidomide is one of the immunomodulating agents used in current oncology practice. We present a case of hemorrhagic rash induced by thalidomide in a patient with delta granule storage pool disease. The patient was getting thalidomide for underlying myelofibrosis.